STAT3 negatively regulates type I IFN-mediated antiviral response

Area of Science:

• Immunology
• Virology
• Molecular Biology

Background:

• Type I interferons (IFNs) are critical for innate immunity against viruses.
• STAT1 and STAT2 are known to mediate type I IFN antiviral responses.
• The specific role of STAT3 in type I IFN signaling has remained largely undetermined.

Purpose of the Study:

• To elucidate the function of STAT3 in type I IFN-mediated antiviral responses.
• To investigate whether STAT3 acts as a positive or negative regulator in this pathway.
• To explore potential therapeutic applications targeting STAT3 for viral infections.

Main Methods:

• Utilized gain-of-function and loss-of-function approaches in cellular models.
• Performed STAT3 knockdown and knockout experiments.
• Analyzed gene expression, antiviral activity, and STAT activation upon IFN-α/β stimulation and viral infection.

Main Results:

• STAT3 knockdown or knockout cells showed enhanced gene expression and antiviral activity following type I IFN treatment.
• Restoring STAT3 in knockout cells attenuated the enhanced type I IFN response.
• Absence of STAT3 led to increased type I IFN production, STAT activation, and ISG expression during viral infection, potentially via MDA5.
• STAT3 suppressed IFN response independently of its transcriptional factor function.

Conclusions:

• STAT3 acts as a negative regulator of type I IFN-mediated antiviral responses.
• STAT3's N-terminal domain plays a role in suppressing IFN response.
• Targeting STAT3 presents a promising therapeutic avenue for managing viral infections.